Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease

NCT01992692 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT01992692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil Requirement in Patients Receiving Surgical Treatment of Parkinson's Disease
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2013
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease